Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Executive Briefing Series (formerly The Food & Drug Letter) > Will FDA Punish Drug Compounder? Rep. Markey Asks

Executive Briefing Series (formerly The Food & Drug Letter)

Nov. 2, 2012

Will FDA Punish Drug Compounder? Rep. Markey Asks

Rep. Edward Markey (D-Mass.) continues to push the FDA for answers about how it will respond to a compounding pharmacy linked to several deaths.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives

Related Articles

FDA Releases Lists of NECC Customers Possibly Receiving Contaminated Drugs GAO Investigation Sought Into NECC, Congressional Probe Heats Up Report: Rogue Compounder Flouted USP Aseptic Practices, Pharmacy Law Mass. Launches Surprise Inspections After NECC Meningitis Outbreak

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.